Concepts (151)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prostatic Hyperplasia | 5 | 2021 | 25 | 3.220 |
Why?
|
| Embolization, Therapeutic | 6 | 2022 | 150 | 3.120 |
Why?
|
| Prostate | 5 | 2021 | 116 | 3.050 |
Why?
|
| Arteries | 5 | 2022 | 108 | 2.340 |
Why?
|
| Lower Urinary Tract Symptoms | 3 | 2021 | 13 | 2.060 |
Why?
|
| Epigastric Arteries | 2 | 2017 | 10 | 0.950 |
Why?
|
| Synovitis | 1 | 2022 | 8 | 0.870 |
Why?
|
| Osteoarthritis, Knee | 1 | 2022 | 26 | 0.850 |
Why?
|
| Cone-Beam Computed Tomography | 1 | 2021 | 52 | 0.760 |
Why?
|
| Radiography, Interventional | 1 | 2020 | 49 | 0.730 |
Why?
|
| Radiation Exposure | 1 | 2021 | 84 | 0.710 |
Why?
|
| Terminology as Topic | 1 | 2020 | 141 | 0.690 |
Why?
|
| Radiation Dosage | 1 | 2021 | 419 | 0.640 |
Why?
|
| Uterine Artery Embolization | 1 | 2017 | 1 | 0.600 |
Why?
|
| Computed Tomography Angiography | 2 | 2021 | 424 | 0.600 |
Why?
|
| Gelatin Sponge, Absorbable | 1 | 2017 | 8 | 0.600 |
Why?
|
| Postpartum Hemorrhage | 1 | 2017 | 12 | 0.600 |
Why?
|
| Uterine Artery | 1 | 2017 | 5 | 0.600 |
Why?
|
| Vascular Malformations | 1 | 2017 | 19 | 0.580 |
Why?
|
| Clinical Trials as Topic | 1 | 2020 | 848 | 0.550 |
Why?
|
| Jejunum | 1 | 2015 | 26 | 0.550 |
Why?
|
| Research Design | 1 | 2020 | 729 | 0.540 |
Why?
|
| Vena Cava, Inferior | 1 | 2015 | 41 | 0.530 |
Why?
|
| Catheterization, Peripheral | 1 | 2015 | 38 | 0.520 |
Why?
|
| Prosthesis Implantation | 1 | 2015 | 83 | 0.510 |
Why?
|
| Gastrostomy | 1 | 2015 | 110 | 0.500 |
Why?
|
| Jugular Veins | 1 | 2014 | 37 | 0.500 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2015 | 134 | 0.480 |
Why?
|
| Surgical Flaps | 2 | 2012 | 120 | 0.480 |
Why?
|
| Angioplasty, Balloon | 1 | 2014 | 110 | 0.470 |
Why?
|
| Catheterization, Central Venous | 1 | 2014 | 89 | 0.470 |
Why?
|
| Renal Dialysis | 1 | 2014 | 174 | 0.460 |
Why?
|
| Mastectomy | 2 | 2010 | 56 | 0.460 |
Why?
|
| Mammaplasty | 2 | 2009 | 41 | 0.430 |
Why?
|
| Pressure Ulcer | 1 | 2012 | 40 | 0.410 |
Why?
|
| Treatment Outcome | 7 | 2021 | 7028 | 0.410 |
Why?
|
| Stents | 1 | 2015 | 657 | 0.390 |
Why?
|
| Thoracic Wall | 1 | 2010 | 20 | 0.370 |
Why?
|
| Perforator Flap | 1 | 2009 | 10 | 0.360 |
Why?
|
| Carcinoma | 1 | 2010 | 215 | 0.330 |
Why?
|
| Biocompatible Materials | 1 | 2010 | 247 | 0.320 |
Why?
|
| Humans | 20 | 2022 | 68525 | 0.320 |
Why?
|
| Male | 12 | 2022 | 37281 | 0.320 |
Why?
|
| Collagen | 1 | 2010 | 636 | 0.300 |
Why?
|
| Angiography | 3 | 2017 | 194 | 0.240 |
Why?
|
| Postoperative Complications | 1 | 2010 | 1615 | 0.210 |
Why?
|
| Time Factors | 4 | 2021 | 4655 | 0.210 |
Why?
|
| Sheep | 1 | 2022 | 128 | 0.210 |
Why?
|
| Knee Joint | 1 | 2022 | 115 | 0.210 |
Why?
|
| Breast Neoplasms | 1 | 2010 | 1533 | 0.190 |
Why?
|
| Middle Aged | 6 | 2021 | 21119 | 0.180 |
Why?
|
| Consensus | 1 | 2020 | 211 | 0.170 |
Why?
|
| Phlebography | 2 | 2017 | 31 | 0.160 |
Why?
|
| Liver Circulation | 1 | 2017 | 40 | 0.160 |
Why?
|
| Portal Vein | 1 | 2017 | 46 | 0.160 |
Why?
|
| Punctures | 2 | 2014 | 35 | 0.150 |
Why?
|
| Predictive Value of Tests | 1 | 2021 | 1465 | 0.150 |
Why?
|
| Venous Thrombosis | 1 | 2017 | 124 | 0.140 |
Why?
|
| Prostate-Specific Antigen | 1 | 2016 | 138 | 0.140 |
Why?
|
| Female | 7 | 2017 | 38015 | 0.140 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2022 | 2222 | 0.130 |
Why?
|
| Equipment Failure | 1 | 2015 | 112 | 0.130 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2020 | 503 | 0.130 |
Why?
|
| Kallikreins | 1 | 2016 | 323 | 0.130 |
Why?
|
| Aged | 4 | 2021 | 14842 | 0.130 |
Why?
|
| Disease Models, Animal | 1 | 2022 | 2550 | 0.120 |
Why?
|
| Fluoroscopy | 1 | 2015 | 152 | 0.120 |
Why?
|
| Central Venous Catheters | 1 | 2014 | 19 | 0.120 |
Why?
|
| Vascular Patency | 1 | 2014 | 122 | 0.120 |
Why?
|
| Catheters, Indwelling | 1 | 2014 | 72 | 0.120 |
Why?
|
| Adult | 5 | 2017 | 21375 | 0.120 |
Why?
|
| Radiography | 1 | 2015 | 572 | 0.120 |
Why?
|
| Liver Cirrhosis | 1 | 2017 | 301 | 0.120 |
Why?
|
| Constriction, Pathologic | 1 | 2014 | 236 | 0.120 |
Why?
|
| Prospective Studies | 1 | 2021 | 3702 | 0.110 |
Why?
|
| Ultrasonography | 1 | 2014 | 453 | 0.110 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 4843 | 0.100 |
Why?
|
| Femur | 1 | 2012 | 113 | 0.100 |
Why?
|
| Pilot Projects | 1 | 2015 | 1341 | 0.100 |
Why?
|
| Pectoralis Muscles | 1 | 2010 | 12 | 0.100 |
Why?
|
| Radiology, Interventional | 1 | 2010 | 21 | 0.100 |
Why?
|
| Sternum | 1 | 2010 | 19 | 0.100 |
Why?
|
| Congresses as Topic | 1 | 2010 | 85 | 0.090 |
Why?
|
| Cholestasis, Extrahepatic | 1 | 2010 | 14 | 0.090 |
Why?
|
| Vascular Diseases | 1 | 2010 | 94 | 0.090 |
Why?
|
| Stomach Diseases | 1 | 2010 | 22 | 0.090 |
Why?
|
| Stomach | 1 | 2010 | 80 | 0.090 |
Why?
|
| Emphysema | 1 | 2010 | 32 | 0.090 |
Why?
|
| Receptors, Prostaglandin E | 1 | 2009 | 8 | 0.090 |
Why?
|
| Epoprostenol | 1 | 2009 | 71 | 0.090 |
Why?
|
| Drainage | 1 | 2010 | 133 | 0.090 |
Why?
|
| Vascular Surgical Procedures | 1 | 2010 | 168 | 0.090 |
Why?
|
| Abdominal Pain | 1 | 2010 | 97 | 0.090 |
Why?
|
| Catheterization | 1 | 2010 | 209 | 0.080 |
Why?
|
| Dinoprostone | 1 | 2009 | 110 | 0.080 |
Why?
|
| Quality of Life | 1 | 2016 | 1515 | 0.080 |
Why?
|
| Societies, Medical | 1 | 2010 | 403 | 0.080 |
Why?
|
| Catheter Ablation | 1 | 2010 | 229 | 0.080 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2008 | 235 | 0.070 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2008 | 200 | 0.070 |
Why?
|
| Endothelial Cells | 1 | 2009 | 384 | 0.070 |
Why?
|
| Animals | 2 | 2022 | 20877 | 0.070 |
Why?
|
| Colonic Neoplasms | 1 | 2008 | 299 | 0.070 |
Why?
|
| Follow-Up Studies | 1 | 2010 | 3256 | 0.060 |
Why?
|
| Retrospective Studies | 1 | 2015 | 7264 | 0.060 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2010 | 2323 | 0.050 |
Why?
|
| Signal Transduction | 1 | 2009 | 2688 | 0.050 |
Why?
|
| Adolescent | 1 | 2012 | 8903 | 0.040 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2017 | 21 | 0.040 |
Why?
|
| Blood Flow Velocity | 1 | 2017 | 172 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2017 | 621 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2017 | 1548 | 0.030 |
Why?
|
| Bibliometrics | 1 | 2010 | 25 | 0.020 |
Why?
|
| Asia | 1 | 2010 | 59 | 0.020 |
Why?
|
| North America | 1 | 2010 | 111 | 0.020 |
Why?
|
| Europe | 1 | 2010 | 195 | 0.020 |
Why?
|
| Biliary Tract Surgical Procedures | 1 | 2010 | 9 | 0.020 |
Why?
|
| Cholangiography | 1 | 2010 | 55 | 0.020 |
Why?
|
| Gastroscopy | 1 | 2010 | 45 | 0.020 |
Why?
|
| Anastomosis, Surgical | 1 | 2010 | 104 | 0.020 |
Why?
|
| Caproates | 1 | 2009 | 3 | 0.020 |
Why?
|
| Celecoxib | 1 | 2009 | 22 | 0.020 |
Why?
|
| Peroxisome Proliferator-Activated Receptors | 1 | 2009 | 7 | 0.020 |
Why?
|
| Bridged Bicyclo Compounds | 1 | 2009 | 29 | 0.020 |
Why?
|
| Response Elements | 1 | 2009 | 29 | 0.020 |
Why?
|
| Thromboplastin | 1 | 2009 | 21 | 0.020 |
Why?
|
| Medical Oncology | 1 | 2010 | 110 | 0.020 |
Why?
|
| Cerebrovascular Disorders | 1 | 2010 | 182 | 0.020 |
Why?
|
| Aortic Diseases | 1 | 2010 | 113 | 0.020 |
Why?
|
| Peripheral Arterial Disease | 1 | 2010 | 83 | 0.020 |
Why?
|
| Blood Coagulation | 1 | 2009 | 123 | 0.020 |
Why?
|
| Azoxymethane | 1 | 2008 | 28 | 0.020 |
Why?
|
| Dextran Sulfate | 1 | 2008 | 88 | 0.020 |
Why?
|
| Sulfonamides | 1 | 2009 | 141 | 0.020 |
Why?
|
| Equipment Design | 1 | 2010 | 500 | 0.020 |
Why?
|
| Pyrazoles | 1 | 2009 | 190 | 0.020 |
Why?
|
| Cyclooxygenase 2 | 1 | 2008 | 160 | 0.020 |
Why?
|
| Risk Factors | 1 | 2017 | 5719 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2008 | 282 | 0.020 |
Why?
|
| Lysophospholipids | 1 | 2008 | 209 | 0.020 |
Why?
|
| Sphingosine | 1 | 2008 | 315 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2010 | 1139 | 0.020 |
Why?
|
| Fibrinolytic Agents | 1 | 2009 | 377 | 0.020 |
Why?
|
| Cell Line | 1 | 2009 | 1752 | 0.020 |
Why?
|
| Cytokines | 1 | 2009 | 866 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2008 | 756 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2008 | 1692 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2009 | 1293 | 0.010 |
Why?
|
| Inflammation | 1 | 2008 | 1030 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 2009 | 938 | 0.010 |
Why?
|
| Mice | 1 | 2008 | 8472 | 0.010 |
Why?
|